Skip to content

A study on the efficacy of the cTBS treatment for auditory hallucinations in schizophrenia

A study on the efficacy of the cTBS treatment for auditory hallucinations in schizophrenia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092279
Enrollment
Unknown
Registered
2024-11-13
Start date
2023-11-20
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

research group:Continuous theta burst stimulation
control subjects:sham stimulation

Sponsors

Shandong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. meet the DSM-5 diagnostic criteria for schizophrenia; 2. age 18-50 years old, male or female; 3. current presence of hallucinatory symptoms, with hallucinations occurring more than 5 times a day for more than 2 weeks; 4. PANSS Hallucination Scale score = 4; 5. stable antipsychotic medication prior to enrollment, with medication regimen remaining unchanged throughout the course of the study.

Exclusion criteria

Exclusion criteria: 1. with serious organic brain diseases, such as epilepsy; 2. with serious somatic diseases, such as cardiovascular diseases, liver and kidney diseases; 3. with contraindications to TMS treatment; 4. pregnant or lactating women; 5. having received MECT treatment or transcranial magnetic stimulation in the last six months.

Design outcomes

Primary

MeasureTime frame
Positive and Negative Syndrome Scale, PANSS;Auditory Hallucination Rating Scale, AHRS;

Countries

China

Contacts

Public ContactShan Xiaoxiao

Shandong Mental Health Center

shanxiaoxiao22@126.com+86 156 6666 4337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026